MAM
ALDR

Meeder Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Meeder Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-73
Closed -$1K – 1874
2017
Q3 		$1K Sell
73
-74
-50% -$772 ﹤0.01% 1593
2017
Q2 		$2K Sell
147
-103
-41% -$1.9K ﹤0.01% 1467
2017
Q1 		$5K Buy
+250
New +$5.53K ﹤0.01% 1124
2016
Q3 		– Sell
-2,665
Closed -$67K – 1029
2016
Q2 		$67K Sell
2,665
-1,942
-42% -$52.5K 0.01% 696
2016
Q1 		$113K Hold
4,607
– – 0.01% 682
2015
Q4 		$152K Hold
4,607
– – 0.01% 567
2015
Q3 		$151K Buy
+4,607
New +$196K 0.01% 541

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return